CaviWipes™ 2.0

The next-generation CaviWipes 2.0 builds on a decades-long reputation of being trusted by clinicians with strong efficacy claims paramount during times of a public health crisis.
mail Email to a Friend
Product Description

Fully qualifies for the EPA’s rigorous Emerging Viral Pathogen Claim.

Features and Benefits:

  • Proven effective against SARS-CoV-2 on hard, non-porous surfaces
  • On EPA List Q*
  • Qualifies for the EPA’s Emerging Viral Pathogens Claim for all virus types (enveloped, large and small non-enveloped viruses) to meet current and potential future infection prevention needs
  • Enhanced Efficacy Claims – Effective against 60 relevant pathogens including Norovirus and Candida auris for added confidence in preventing healthcare associated infections
  • Excellent Material Compatibility – Compatible with most non-porous, hard surfaces commonly used in clinical settings
  • Easy-To-Use Label – Makes it quick and easy to find critical information on efficacy, compatibility, and more
  • 2-minute universal contact time for bacteria, viruses, and pathogenic fungi (Candida auris)
Pesticide Registration Disinfectants for Emerging Viral Pathogens (EVPs): List Q. Retrieved 10.03.2022
Specifications
Brand Metrex
Assembly Required No
Reviews
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account
Documents
Did You Know
Did You Know
Warnings
Choking Hazard No
Sterile No